Trabectedin: A drug from the sea that strikes tumor-associated macrophages.

Trabectedin: A drug from the sea that strikes tumor-associated macrophages.
复制标题

DOI:
10.4161/onci.24614
复制
发表时间:
2013-06-01
期刊:
影响因子:
7.2
通讯作者:
Mantovani A
Mantovani A
中科院分区:
医学2区
文献类型:
--
作者:
Allavena P;Germano G;Belgiovine C;D'Incalci M;Mantovani A

文献摘要

参考文献

被引文献

相似文献

肿瘤相关巨噬细胞(tam)和其他骨髓细胞浸润肿瘤病变,促进肿瘤进展,并与患者预后不良相关。我们最近证明了trabectedin,一种获得许可和市售的抗癌剂,对tam及其循环前体(单核细胞)具有选择性细胞毒性。trabectedin的巨噬细胞消耗作用是其抗肿瘤活性的关键组成部分。
Tumor-associated macrophages (TAMs) and other myeloid cells that infiltrate neoplastic lesions promote tumor progression and are associated with poor patient prognosis. We have recently demonstrated that trabectedin, a licensed and commercially available anticancer agent, is selectively cytotoxic for TAMs and their circulating precursors (monocytes). The macrophage-depleting effect of trabectedin is a key component of its antitumor activity.
DOI: 10.1016/s1470-2045(07)70175-4
发表时间: 2007-07-01
期刊: LANCET ONCOLOGY
影响因子: 51.1
作者:
Grosso, Federica;Jones, Robin L.;Casali, Paola G.
通讯作者: Casali, Paola G.
DOI: 10.1016/j.cell.2010.03.014
发表时间: 2010-04-02
期刊: Cell
影响因子: 64.5
作者:
Qian BZ;Pollard JW
通讯作者: Pollard JW
DOI: 10.1056/nejmoa0905680
发表时间: 2010-03-11
期刊: The New England journal of medicine
影响因子: --
作者:
Steidl C;Lee T;Shah SP;Farinha P;Han G;Nayar T;Delaney A;Jones SJ;Iqbal J;Weisenburger DD;Bast MA;Rosenwald A;Muller-Hermelink HK;Rimsza LM;Campo E;Delabie J;Braziel RM;Cook JR;Tubbs RR;Jaffe ES;Lenz G;Connors JM;Staudt LM;Chan WC;Gascoyne RD
通讯作者: Gascoyne RD
DOI: 10.1016/j.ccr.2013.01.008
发表时间: 2013-02-11
期刊: CANCER CELL
影响因子: 50.3
作者:
Germano, Giovanni;Frapolli, Roberta;Allavena, Paola
通讯作者: Allavena, Paola
DOI: 10.1158/2159-8274.cd-10-0028
发表时间: 2011-06
期刊: Cancer discovery
影响因子: 28.2
作者:
DeNardo DG;Brennan DJ;Rexhepaj E;Ruffell B;Shiao SL;Madden SF;Gallagher WM;Wadhwani N;Keil SD;Junaid SA;Rugo HS;Hwang ES;Jirström K;West BL;Coussens LM
通讯作者: Coussens LM